The Journal of Immunology, Vol 144, Issue 1 153-161, Copyright © 1990 by American Association of Immunologists

ARTICLES

Detection of neutrophil-activating peptide NAP/IL-8 and NAP/IL-8 mRNA in human recombinant IL-1 alpha- and human recombinant tumor necrosis factor-alpha-stimulated human dermal fibroblasts. An immunocytochemical and fluorescent in situ hybridization study

V Mielke, JG Bauman, M Sticherling, T Ibs, AG Zomershoe, K Seligmann, HH Henneicke, JM Schroder, W Sterry and E Christophers
Department of Dermatology, University of Kiel, Federal Republic of Germany.

A neutrophil-activating peptide (NAP)/IL-8 produced by LPS-stimulated human peripheral blood monocytes was biochemically purified and functionally characterized by different investigators. Work conducted in our laboratory showed that NAP/IL-8 as well as variants of this peptide are produced by a variety of cells (e.g., monocytes, T lymphocytes, endothelial cells) and that lesional psoriatic scales contain large amounts of biologically active NAP/IL-8. We now investigated human dermal fibroblasts for production of NAP/IL-8. The peptide was detected by immunocytochemistry by using the mAb 46E5. NAP/IL-8 mRNA was visualized by high resolutive fluorescent in situ hybridization with biotinylated antisense/sense RNA probes. Among the various stimuli used [human (h)rIL-1 alpha, hrTNF-alpha, hrIL-3, hr- granulocyte-macrophage-CSF, LPS, FMLP, and platelet-activating factor (PAF)] only hrIL-1 alpha (100 U/ml) and hrTNF-alpha (100 ng/ml) induced the transcription and translation of NAP/IL-8. In contrast to monocytes, LPS was without effect in cultured human dermal fibroblasts. Both NAP/IL-8 and NAP/IL-8 mRNA were found in the cytoplasm adjacent to the nucleus, but interestingly NAP/IL-8 mRNA was not restricted to the cytoplasm. In positive cells only two small bright spots were randomly distributed in the nucleus. Most likely these spots represent transcription sites where NAP/IL-8 mRNA is accumulated during gene expression. Our observations show that stimulation of dermal fibroblasts with the cytokines hrIL-1 alpha and hrTNF-alpha results in expression of IL-8.

This article has been cited by other articles:

				F. Egberts, M. Heinrich, J.-M. Jensen, S. Winoto-Morbach, S. Pfeiffer, M. Wickel, M. Schunck, J. Steude, P. Saftig, E. Proksch, et al. Cathepsin D is involved in the regulation of transglutaminase 1 and epidermal differentiation J. Cell Sci., May 1, 2004; 117(11): 2295 - 2307. [Abstract] [Full Text] [PDF]

				K. Shimoya, A. Moriyama, N. Matsuzaki, I. Ogata, M. Koyama, C. Azuma, F. Saji, and Y. Murata Human placental cells show enhanced production of interleukin (IL)-8 in response to lipopolysaccharide (LPS), IL-1 and tumour necrosis factor (TNF)-{alpha}, but not to IL-6 Mol. Hum. Reprod., September 1, 1999; 5(9): 885 - 885. [Abstract] [Full Text] [PDF]

				C. B. Marsh, M. P. Lowe, B. H. Rovin, J. M. Parker, Z. Liao, D. L. Knoell, and M. D. Wewers Lymphocytes Produce IL-1{beta} in Response to Fc{gamma} Receptor Cross-Linking: Effects on Parenchymal Cell IL-8 Release J. Immunol., April 15, 1998; 160(8): 3942 - 3948. [Abstract] [Full Text] [PDF]

				H. Harant, R. de Martin, P. J. Andrew, E. Foglar, C. Dittrich, and I. J.D. Lindley Synergistic Activation of Interleukin-8 Gene Transcription by All-trans-retinoic Acid and Tumor Necrosis Factor-alpha Involves the Transcription Factor NF-kappa B J. Biol. Chem., October 25, 1996; 271(43): 26954 - 26961. [Abstract] [Full Text] [PDF]